Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stereotaxis Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
STXS
Exposures
Financial
Product Safety
NeurAxis (NRXS) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
NRXS
Exposures
Financial
Product Safety
Taysha Gene Therapies Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
TSHA
Exposures
Financial
Product Safety
Precigen (PGEN) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
PGEN
Exposures
Financial
Product Safety
NeuroPace Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
NPCE
Exposures
Financial
Product Safety
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
August 11, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Spectral AI Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Tickers
MDAI
Exposures
Artificial Intelligence
Financial
Product Safety
Mineralys Therapeutics Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Earnings
Initial Public Offering
Tickers
MLYS
Exposures
Financial
Product Safety
Securities Market
Kaplan Fox Alerts Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Possible Securities Law Violations
August 11, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
August 11, 2026
Via
NewMediaWire
Tickers
BAC
MDLN
Exposures
Product Safety
SignalPGx Launches White-Label Pharmacogenomics Reporting Platform for CLIA Laboratories
August 11, 2026
Via
Get News
Exposures
Product Safety
Arvinas (ARVN) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
ARVN
PFE
Exposures
Financial
Product Safety
Palvella (PVLA) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
PVLA
Exposures
Financial
Product Safety
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026
August 11, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Merck (MRK) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Tickers
MRK
Exposures
Financial
Intellectual Property
Product Safety
Gym Rats Made Peptides Go Viral. California Trim Clinic Says Peptides Need More Than Mystery Vials!
August 11, 2026
Via
PRUnderground
Exposures
Product Safety
Harrow Q2 Earnings Call Highlights
↗
August 11, 2026
Via
MarketBeat
Topics
Earnings
Tickers
HROW
Exposures
Financial
Product Safety
Robbins LLP Urges CAPR Stockholders Who Lost Money Investing in Capricor Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
August 11, 2026
Via
Newsfile
Topics
Lawsuit
Tickers
CAPR
Exposures
Financial
Legal
Product Safety
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates
↗
August 11, 2026
Via
Benzinga
Exposures
Product Safety
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase
August 11, 2026
Via
NewMediaWire
Tickers
GOVX
Exposures
Product Safety
Taylor Farms Recalls Jalapeño Products Amid Salmonella Outbreak— Chuck Schumer Says Trump Is Doing Everything to ‘Make America Sick Again’
↗
August 11, 2026
Via
Benzinga
Topics
Government
Product Recall
Exposures
Legal
Political
Product Safety
Timothy Bradbury Monzello Calls for Stronger Manufacturing Education and Practical Engineering Skills
August 11, 2026
Via
24-7 Press Release
Topics
Product Recall
Exposures
Legal
Product Safety
Constar Reaches 15 Million Monthly Lens Production Capacity Across Six China Facilities
August 11, 2026
Via
AB Newswire
Topics
Economy
Exposures
Product Safety
Supply Chain
PRISM Medical Care Positions Nevada Patients for Safe, Clinically Supervised GLP-1 Therapy as Federal Scrutiny of Prescription Mills Intensifies
August 11, 2026
Via
AB Newswire
Exposures
Product Safety
Best VELO Nicotine Pouches in 2026: Buyer's Guide | USA NICO
↗
August 11, 2026
Via
Talk Markets
Exposures
Product Safety
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
↗
August 11, 2026
Via
MarketBeat
Tickers
SLN
Exposures
Product Safety
Oncocyte Q2 Earnings Call Highlights
↗
August 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
IMDX
Exposures
Financial
Product Safety
Fractyl Health Q2 Earnings Call Highlights
↗
August 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
GUTS
Exposures
Financial
Product Safety
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026
August 10, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
August 10, 2026
Via
NewMediaWire
Tickers
MDLN
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.